Orchid Cellmark (NASDAQ: ORCH) CEO InterviewOrchid Cellmark (NASDAQ: ORCH) CEO InterviewThis interview has expired. Special deals for our readers Be a more profitable investor: Get an Equifax 3-in-1 Credit Report Now! Why are you still paying too much with Schwab, and and E-trade?? Step up to the #1 discount broker: TradeKing. Invest Smarter! Get 4 Bonus Weeks of Investor’s Business Daily Digital Edition! LifeLock is the only Identity Theft Prevention Solution backed by a one-million dollar guarantee!Click here to get a 10% discount. Get FICO Score Watch Now! Click here to get access to powerful investing tools only available at Investor’s Business Daily. Get a free look at Jim Cramer’s Action Alerts PLUS portfolio. Click here
Orchid Cellmark Inc. is engaged in the provision of deoxyribonucleic acid (DNA) testing services that generate genetic profile information by analyzing an organism’s genetic identity. The Company’s business focuses on DNA testing for human identity and agricultural applications. In the human identity area, the Company provides DNA testing services for forensic, family relationship, and security applications. In agricultural applications, the Company provides DNA testing services for selective trait breeding. The Company has operations in the United States and in the United Kingdom. The Company’s forensic, family relationship, and security DNA testing services are conducted in both the United States and the United Kingdom, while all of its agricultural DNA testing services are conducted in the United Kingdom. Leave a Reply |
|
Standard Podcast [14:33m]: 
WSR Recommends |
||
| Special Deal for Our Readers (That’s You!) | Jim Cramer: The Clown That Makes You Money | Get Rich with Fibonacci. Learn How to Use Fibonacci Analysis to Trade Better. |
